Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: Preparation, physicochemical properties and cytotoxicity

Colloids and Surfaces B: Biointerfaces

Volumn 101, Issue , 2013, Pages 215-222

  Yordanov, Georgi ^a   Skrobanska, Ralica ^a   Evangelatov, Alexander ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

A549; Apoptosis; Cancer; Cytotoxicity; Etoposide; Nanoparticles; Poly(butyl cyanoacrylate)

Indexed keywords

A549; ADENOCARCINOMA CELLS; AQUEOUS MEDIUM; AVERAGE SIZE; BUTYL CYANOACRYLATE; CANCER; COLLOIDAL STABILIZERS; CYTOTOXICITY ASSESSMENT; DRUG-LOADING EFFICIENCY; ETOPOSIDE; INDUCED APOPTOSIS; NONIONIC; PHYSICO-CHEMICAL CHARACTERIZATION; PHYSICOCHEMICAL PROPERTY; PLURONIC-F68; POLYSORBATE 80;

ADHESIVES; BIOMATERIALS; CELL DEATH; CYTOTOXICITY; DIALYSIS; EMULSION POLYMERIZATION; EMULSIONS;

NANOPARTICLES;

CYANOACRYLATE DERIVATIVE; ENBUCRILATE; ETOPOSIDE; NANOPARTICLE; POLOXAMER; POLY(BUTYL CYANOACRYLATE); POLYSORBATE 80; SURFACTANT; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADSORPTION KINETICS; ANALYTICAL PARAMETERS; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CELL NUCLEUS; CELL VIABILITY; CHROMATIN CONDENSATION; COLLOID; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSIS; DISPERSION; DRUG COATING; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EMULSION; EPITHELIUM CELL; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PARTICLE SIZE; PH MEASUREMENT; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; SIZE DISTRIBUTION; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZIMIDAZOLES; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; COLORING AGENTS; ENBUCRILATE; ETOPOSIDE; FLUORESCENT DYES; HUMANS; INDICATORS AND REAGENTS; LIGHT; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; SCATTERING, RADIATION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84864398910     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.05.040     Document Type: Article

References (70)

1. Hande K.R. Eur. J. Cancer 1998, 34:1514.
2. Aisner J., Lee E. Cancer 1991, 67:215.
3. Greco F.A. Cancer 1991, 67:315.
4. Slevin M.L. Cancer 1991, 67:319.
5. Joel S. Cancer Treat. Rev. 1996, 22:179.
6. Chevrier R., Sautou V., Pinon V., Demeocq F., Chopineau J. Pharm. Acta Helv. 1995, 70:141.
7. Jain N., Lam Y.M., Pym J., Campling B.G. Cancer 1996, 77:1797.
8. Kreuter J. Int. J. Pharm. 2007, 331:1.
9. Faraji A., Wipf P. Bioorg. Med. Chem. 2009, 17:2950.
10. Ruenraroengsak P., Cook J., Florence A. J. Control. Release 2010, 141:265.
11. Wang F., Bronich T., Kabanov A., Rauh R., Roovers J. Bioconjug. Chem. 2005, 16:397.
12. Reddy L.H., Sharma R.K., Murthy R.R. Acta Pharm. 2006, 56:143.
13. Reddy P.R., Venkateswarlu V. J. Drug Target. 2005, 13:543.
14. Sengupta S., Tyagi P., Velpandian T., Gupta Y.K., Gupta S.K. Pharmacol. Res. 2000, 42:459.
15. Sengupta S., Tyagi P., Chandra S., Kochupillai V., Gupta S.K. Pharmacology 2001, 62:163.
16. Sant V.P., Nagarsenker M.S., Rao S.G.A., Gude R.P. Cancer Biother. Radiopharm. 2003, 18:811.
17. Fiorillo A., Maggi G., Greco N., Migliorati R., D'Amico A., Del Basso De Caro M., Sabbatino M.S., Buffardi F. J. Neuro-Oncol. 2004, 66:179.
18. Combs S., Neil N., Aboulafia D.M. Oncologist 2006, 11:666.
19. Reddy L., Sharma R., Chuttani K., Mishra A., Murthy R. AAPS J. 2004, 6. Article 23. http://www.aapsj.org/.
20. Reddy L., Sharma R., Chuttani K., Mishra A., Murthy R. J. Control. Release 2005, 105:185.
21. Reddy L., Murthy R. AAPS PharmSciTech. 2005, 6:E158.
22. Lamprecht A., Benoit J.P. J. Control. Release 2006, 112:208.
23. Reddy L., Adhikari J., Dwarakanath B., Sharma R., Murthy R. AAPS J. 2006, 8:E254.
24. Snehalatha M., Venugopal K., Saha R.N., Babbar A.K., Sharma R.K. Drug Deliv. 2008, 15:277.
25. Acharya S., Sahoo S.K. Adv. Drug Deliv. Rev. 2011, 63:170.
26. Yadav K.S., Chuttani K., Mishra A.K., Sawant K.K. Drug Dev. Res. 2010, 71:228.
27. Schaefer M.J., Singh J. Biomaterials 2002, 23:3465.
28. Tang B.C., Fu J., Watkins D.N., Hanes J. Biomaterials 2010, 31:339.
29. Gabizon A.A. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London, (Chapter 20). V. Torchilin (Ed.).
30. Lawrence M.J., Warisnoicharoen W. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London, (Chapter 7). V. Torchilin (Ed.).
31. Mäder K. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London, (Chapter 9). V. Torchilin (Ed.).
32. Murthy R., Reddy L. Nanotechnology for Cancer Therapy 2006, CRC Press. M.M. Amiji (Ed.).
33. Nicolas J., Couvreur P. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1:111.
34. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., Couvreur P. Adv. Drug Deliv. Rev. 2003, 55:519.
35. Gulyaev A., Ermekbaeva B., Kivman G., Radchenko T., Sherstov A., Shirinskii V. Pharm. Chem. J. 1998, 32:3.
36. Pinto-Alphandary H., Andremont A., Couvreur P. Int. J. Antimicrob. Agents 2000, 13:155.
37. Fattal E., Youssef M., Couvreur P., Andremont A. Antimicrob. Agents Chemother. 1989, 33:1540.
38. Kisich K., Gelperina S., Higgins M., Wilson S., Shipulo E., Oganesyan E., Heifets L. Int. J. Pharm. 2007, 345:154.
39. Fontana G., Licciardi M., Mansueto S., Schillaci D., Giammona G. Biomaterials 2001, 22:2857.
40. Cavallaro G., Fresta M., Giammona G., Puglisi G., Villari A. Int. J. Pharm. 1994, 111:31.
41. Arias J., Ruiz A., Lopez-Viota M., Delgado A. Colloid Surface B 2008, 62:64-70.
42. Petri B., Bootz A., Khalansky A., Hekmatara T., Müller R., Uhl R., Kreuter J., Gelperina S. J. Control. Release 2007, 117:51.
43. Kreuter J., Alyautdin R., Kharkevich D., Ivanov A. Brain Res. 1995, 674:171.
44. Arias J., Gallardo V., Ruiz A., Delgado A. Eur. J. Pharm. Biopharm. 2008, 69:54.
45. Briesen H., Ramge P., Kreuter J. AIDS Rev. 2000, 2:31.
46. Kuo Y. Int. J. Pharm. 2005, 290:161.
47. Lambert G., Fattal E., Pinto-Alphandary H., Gulik A., Couvreur P. Pharm. Res. 2000, 17:707.
48. Zhang Q., Shen Z., Nagai T. Int. J. Pharm. 2001, 218:75.
49. Graf A., Jack K., Whittaker A., Hook S., Rades T. Eur. J. Pharm. Sci. 2008, 33:434.
50. Treupel L., Poupon M., Couvreur P., Puisieux F. C. R. Acad. Sci. III 1991, 313:171.
51. Kreuter J. Adv. Drug Deliv. Rev. 2001, 47:65.
52. Azarmi S., Tao X., Chen H., Wang Z., Finlay W.H., Löbenberg R., Roa W.H. Int. J. Pharm. 2006, 319:155.
53. Dziubla T., Muzykantov V. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London, (Chapter 23). V. Torchilin (Ed.).
54. Zhou Q., Sun X., Zeng L., Liu J., Zhang Z. Nanomedicine: NBM 2009, 5:419.
55. Darwish I.A., Florence A.T., Saleh A.M. J. Pharm. Sci. 1989, 78:577.
56. Yordanov G., Skrobanska R., Evangelatov A. Colloids Surface B 2012, 92:98.
57. Yordanov G., Abrashev N., Dushkin C. Prog. Colloid Polym. Sci. 2010, 137:53.
58. Behan N., Birkinshaw C., Clarke N. Biomaterials 2001, 22:1335.
59. Behan N., Birkinshaw C. Macromol. Rapid Commun. 2000, 21:884.
60. Kolhe S., Chipade M., Chaudhari P.D. Int. J. Pharm. Chem. Sci. 2012, 1:129.
61. Arias J., Gallardo V., Gómez-Lopera S., Plaza R., Delgado A. J. Control. Release 2001, 77:309.
62. Aggarwal P., Hall J., McLeland C., Dobrovolskaia M., McNeil S. Adv. Drug Deliv. Rev. 2009, 61:428.
63. Gessner A., Lieske A., Paulke B., Muller R. Eur. J. Pharm. Biopharm. 2002, 54:165.
64. Gessner A., Lieske A., Paulke B.R., Muller R.H. J. Biomed. Mater. Res. A 2003, 65:319.
65. Washington C. Int. J. Pharm. 1990, 58:1.
66. Li-Blatter X., Nervi P., Seelig A. Biochim. Biophys. Acta 2009, 1788:2335.
67. Salomon J., Ehrhardt C. Eur. J. Pharm. Biopharm. 2011, 77:392.
68. Zhivotosky B., Orrenius S. Curr. Protoc. Cell Biol. 2001, Unit 18.3 (Chapter 18).
69. Alexandre J., Batteux F., Nicco C., Chereau C., Laurent A., Guillevin L., Weill B., Goldwasser F. Int. J. Cancer 2006, 119:41.
70. Chen G., Lai P. Apoptosis in Carcinogenesis and Chemotherapy 2009, vol. XXII. Springer, p. 386.